Topical imiquimod is used for a variety of common dermatologic lesions, including melanoma . As an immunomodulator, it is relatively well tolerated with minimal side effects, including scaling, erythema, and edema. Here we present a rare systemic adverse effect, where our patient experienced debilitating severe fatigue when applying imiquimod to a single lesion. Clinicians should be mindful of this side effect and counsel patients appropriately.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/09546634.2022.2125266 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!